Literature DB >> 15665841

Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease.

J Vakkila1, A W Thomson, L Hovi, K Vettenranta, U M Saarinen-Pihkala.   

Abstract

We examined the recovery of circulating monocytoid (Lin- CD11+ HLA-DR+) and plasmacytoid (Lin- CD123+ HLA-DR+) precursor (pre) dendritic cell (DC) subsets after allogeneic stem cell transplantation (SCT) in 39 children, using age-matched healthy children as controls. The frequencies of DCs in peripheral blood samples were determined by flow cytometry. The initial recovery of DC occurred simultaneously with myeloid engraftment. However, with time, DC subset values declined, being very low 40-50 days after SCT. Low monocytoid and plasmacytoid DC values were associated significantly with the development of severe acute graft-versus-host disease (aGVHD) (P=0.042 and 0.017, respectively). Plasmacytoid DC values were lower than in the age-matched controls for the entire follow-up period (range 102-2569 days), although, with time, values approached normal levels. Normal monocytoid DC numbers were observed within 300-400 days post SCT. The severity of chronic GVHD did not correlate with quantitative recovery of DC. We conclude that in pediatric SCT, initial recovery of DC production is concurrent with that of myelopoiesis, yet with time, DC subset values decline and low counts are associated with severe aGVHD. Monocytoid DC numbers approach normal levels within a year of SCT, but plasmacytoid DC counts recover very slowly.

Entities:  

Mesh:

Year:  2005        PMID: 15665841     DOI: 10.1038/sj.bmt.1704827

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  16 in total

1.  Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells.

Authors:  L C J Te Boome; C Mansilla; L E van der Wagen; C A Lindemans; E J Petersen; E Spierings; K A Thus; K Westinga; M Plantinga; M Bierings; A E C Broers; M L H Cuijpers; G W van Imhoff; J J Janssen; C Huisman; S Zeerleder; G Huls; J J Boelens; N M Wulffraat; I C M Slaper-Cortenbach; J Kuball
Journal:  Leukemia       Date:  2015-04-03       Impact factor: 11.528

Review 2.  GVHD: a continuing barrier to the safety of allogeneic transplantation.

Authors:  Pavan Reddy; Mukta Arora; Martin Guimond; Crystal L Mackall
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

3.  Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation.

Authors:  M C Elze; O Ciocarlie; A Heinze; S Kloess; T Gardlowski; R Esser; T Klingebiel; P Bader; S Huenecke; M Serban; U Köhl; J L Hutton
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

4.  Anticipation of Relapse and Acute Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation: The Fundamental Role of Antigen-Presenting (Dendritic) Cells.

Authors:  Khalid Ali Nasif; Awad S Al Samghan; Nahla El-Sharkawy; Amr M Abass; Ebtesam Elgezawy; Safaa A A Khaled; Mahmoud I Elbadry; Marwa M Thabet
Journal:  J Inflamm Res       Date:  2022-06-30

5.  Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction.

Authors:  Yuanyuan Tian; Lijun Meng; Ying Wang; Bohan Li; Hongshuang Yu; Yan Zhou; Tien Bui; Ciril Abraham; Alicia Li; Yongping Zhang; Jian Wang; Chenchen Zhao; Shin Mineishi; Stefania Gallucci; David Porter; Elizabeth Hexner; Hong Zheng; Yanyun Zhang; Shaoyan Hu; Yi Zhang
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 6.  Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?

Authors:  J J Auletta; S M Devine; E K Waller
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

7.  High-content flow cytometry and temporal data analysis for defining a cellular signature of graft-versus-host disease.

Authors:  Ryan Remy Brinkman; Maura Gasparetto; Shang-Jung Jessica Lee; Albert J Ribickas; Janelle Perkins; William Janssen; Renee Smiley; Clay Smith
Journal:  Biol Blood Marrow Transplant       Date:  2007-04-06       Impact factor: 5.742

Review 8.  Human dendritic cells and transplant outcome.

Authors:  Mario G Solari; Angus W Thomson
Journal:  Transplantation       Date:  2008-06-15       Impact factor: 4.939

9.  An alternative flow cytometry strategy for peripheral blood dendritic cell enumeration in the setting of repetitive GM-CSF dosing.

Authors:  Kehui Wang; Kevin P Nishimoto; Rita S Mehta; Edward L Nelson
Journal:  J Transl Med       Date:  2006-04-24       Impact factor: 5.531

Review 10.  Restoring T Cell Homeostasis After Allogeneic Stem Cell Transplantation; Principal Limitations and Future Challenges.

Authors:  Moutuaata M Moutuou; Gabriel Pagé; Intesar Zaid; Sylvie Lesage; Martin Guimond
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.